OncoTargets and Therapy · 2019 · 41 citations · 24 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer BiomarkersCancer Cell SignalingCancer ProgressionLung CancerNoncoding Rna BiologyRna InterferenceCell CountingCell Migration AnalysisCell Migration AssaysCell Migration DynamicsCell Proliferation IndicesNoncoding Rna-mediated Gene RegulationProtein Expression LevelsReal-time Polymerase Chain Reaction (Pcr)
Background: This study aimed to explore the effect of long non-coding RNA (LncRNA) H19 on the proliferation and invasion of lung carcinoma cells A549, and to determine its molecular targets. Methods: A549 cells were with either LncRNA H19 or LncRNA H19 shRNA, and the expression levels of LncRNA H19 were evaluated by quantitative real-time PCR (RT-PCR). We measured cell proliferation using the CCK-8 assay, cell counting assays, and colony formation assay in response to shLncRNA H19-2. Cell migration and invasion were assessed by wound healing assay and Transwell assay, respectively. The mRNA and protein expression levels of E-cadherin, N-cadherin, and vimentin were determined by RT-PCR and western blot, respectively. Results: The three LncRNA H19 shRNAs used in our study significantly reduced the expression levels of LncRNA H19 in A549 cells ( P <0.05). Moreover, LncRNA H19 shRNA 2 (shLncRNA-2) was the most potent inhibitor of LncRNA H19 expression, and was selected for further experimentation. Transfection with shLncRNA H19-2 significantly decreased the proliferation, migration, and invasion of A549 cells, while overexpression of LncRNA H19 had the opposite effect in these cells ( P <0.05). In response to shLncRNA H19-2, the expression levels of E-cadherin were notably elevated ( P <0.05), while the expression levels of N-cadherin and vimentin were decreased ( P <0.05). In contrast, overexpression of LncRNA H19 induced the expression of E-cadherin, and blocked the expression of N-cadherin, and vimentin ( P <0.05). Conclusion: Our results suggest that LncRNA H19 mediates the proliferation and invasion of lung cancer cells via upregulation of N-cadherin and vimentin, and downregulation of E-cadherin. Keywords: long non-coding RNA, lung cancer, E-cadherin, N-cadherin, vimentin
24
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations
Medicine, Immunology, Oncology +17
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text
Medicine, Oncology, Pharmacology +16
The evolution of lncRNA repertoires and expression patterns in tetrapods
Anamaria Necşulea, Magali Soumillon, Maria Warnefors et al. · Nature · 2014 · 1.1K citations · Full text